HRP20141058T1 - DERIVATI 1-PIRAZOLO[4,3-c]IZOKINOLINA, NJIHOVO DOBIVANJE I UPOTREBA U TERAPIJI - Google Patents

DERIVATI 1-PIRAZOLO[4,3-c]IZOKINOLINA, NJIHOVO DOBIVANJE I UPOTREBA U TERAPIJI Download PDF

Info

Publication number
HRP20141058T1
HRP20141058T1 HRP20141058AT HRP20141058T HRP20141058T1 HR P20141058 T1 HRP20141058 T1 HR P20141058T1 HR P20141058A T HRP20141058A T HR P20141058AT HR P20141058 T HRP20141058 T HR P20141058T HR P20141058 T1 HRP20141058 T1 HR P20141058T1
Authority
HR
Croatia
Prior art keywords
group
pyrazolo
difluorophenyl
amino
piperidin
Prior art date
Application number
HRP20141058AT
Other languages
English (en)
Croatian (hr)
Inventor
Georges Delettre
Stéphanie Deprets
Frank Halley
Laurent Schio
Fabienne Thompson
Original Assignee
Sanofi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi filed Critical Sanofi
Publication of HRP20141058T1 publication Critical patent/HRP20141058T1/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HRP20141058AT 2009-04-24 2010-04-22 DERIVATI 1-PIRAZOLO[4,3-c]IZOKINOLINA, NJIHOVO DOBIVANJE I UPOTREBA U TERAPIJI HRP20141058T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0901995A FR2944792B1 (fr) 2009-04-24 2009-04-24 Derives de 1h-pyrazolo[4,3-c]isoquinoleines, leur preparation et leur application en therapeutique
PCT/FR2010/050773 WO2010122272A1 (fr) 2009-04-24 2010-04-22 DERIVES DE 1-PYRAZOLO[4,3-c]ISOQUINOLEINES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE

Publications (1)

Publication Number Publication Date
HRP20141058T1 true HRP20141058T1 (hr) 2014-12-19

Family

ID=41259738

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20141058AT HRP20141058T1 (hr) 2009-04-24 2010-04-22 DERIVATI 1-PIRAZOLO[4,3-c]IZOKINOLINA, NJIHOVO DOBIVANJE I UPOTREBA U TERAPIJI

Country Status (25)

Country Link
US (1) US8461175B2 (enExample)
EP (1) EP2421864B1 (enExample)
JP (1) JP5722880B2 (enExample)
KR (1) KR101675609B1 (enExample)
CN (1) CN102459260B (enExample)
AR (1) AR076393A1 (enExample)
AU (1) AU2010240742B2 (enExample)
BR (1) BRPI1013724A2 (enExample)
CA (1) CA2791947A1 (enExample)
CY (1) CY1115678T1 (enExample)
DK (1) DK2421864T3 (enExample)
ES (1) ES2515240T3 (enExample)
FR (1) FR2944792B1 (enExample)
HR (1) HRP20141058T1 (enExample)
IL (1) IL215733A (enExample)
MX (1) MX2011011246A (enExample)
MY (1) MY156362A (enExample)
PL (1) PL2421864T3 (enExample)
PT (1) PT2421864E (enExample)
RU (1) RU2530775C2 (enExample)
SG (1) SG175338A1 (enExample)
SI (1) SI2421864T1 (enExample)
TW (1) TWI468405B (enExample)
UY (1) UY32575A (enExample)
WO (1) WO2010122272A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109020972B (zh) * 2018-10-08 2021-03-09 广东石油化工学院 一种三唑并[1，5-a]喹啉衍生物的制备方法
WO2023039510A1 (en) * 2021-09-10 2023-03-16 The Trustees Of Columbia University In The City Of New York Gpx4 inhibitors and uses thereof
CN116535356A (zh) * 2023-03-06 2023-08-04 中国药科大学 3-氨基-5-苯基-吡唑类衍生物微管蛋白抑制剂及其制备和医药用途
EP4506003A1 (en) 2023-08-07 2025-02-12 S.Yu Yunusov Institute of Chemistry of Plant Substances of the Academy of Sciences of the Republic of Uzbekistan Halogen derivatives of (4´,5´- methylenedioxyphenyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline for use in the treatment of leukemia

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8600752D0 (en) * 1986-01-14 1986-02-19 Roussel Lab Ltd Chemical compounds
DE10229762A1 (de) * 2002-07-03 2004-01-22 Aventis Pharma Deutschland Gmbh Pyrazoloisoquinolinenderivaten zur Inhibierung von NFkappaB-induzierende Kinase
US7132428B2 (en) * 2003-07-03 2006-11-07 Aventis Pharmaceuticals Inc. Pyrazoloisoquinoline derivative as kinase inhibitors for the treatment of various disorders
CA2531291A1 (en) * 2003-07-03 2005-02-10 Aventis Pharmaceuticals Inc. Pyrazoloisoquinoline derivatives as kinase inhibitors
AU2004259012C1 (en) * 2003-07-23 2012-08-02 Exelixis, Inc. Anaplastic lymphoma kinase modulators and methods of use
AR058223A1 (es) * 2005-11-25 2008-01-23 Palau Pharma Sa Un comuesto de derivados de pirazoloisoquinolina, un procedimiento para l a preparacion de dicho compuesto y una composicion farmaceutica que comprende dicho compuesto

Also Published As

Publication number Publication date
UY32575A (es) 2010-11-30
JP5722880B2 (ja) 2015-05-27
TWI468405B (zh) 2015-01-11
BRPI1013724A2 (pt) 2016-04-05
IL215733A0 (en) 2012-01-31
MX2011011246A (es) 2012-02-13
HK1170736A1 (en) 2013-03-08
WO2010122272A1 (fr) 2010-10-28
TW201041887A (en) 2010-12-01
DK2421864T3 (da) 2014-11-10
FR2944792A1 (fr) 2010-10-29
PT2421864E (pt) 2014-10-07
CN102459260A (zh) 2012-05-16
PL2421864T3 (pl) 2014-12-31
SG175338A1 (en) 2011-11-28
FR2944792B1 (fr) 2011-05-20
EP2421864B1 (fr) 2014-08-06
ES2515240T3 (es) 2014-10-29
RU2011147658A (ru) 2013-05-27
HK1167387A1 (en) 2012-11-30
IL215733A (en) 2014-02-27
EP2421864A1 (fr) 2012-02-29
JP2012524766A (ja) 2012-10-18
KR101675609B1 (ko) 2016-11-11
AR076393A1 (es) 2011-06-08
US8461175B2 (en) 2013-06-11
AU2010240742A1 (en) 2011-11-17
SI2421864T1 (sl) 2014-11-28
MY156362A (en) 2016-02-15
RU2530775C2 (ru) 2014-10-10
KR20120007060A (ko) 2012-01-19
CY1115678T1 (el) 2017-01-25
CN102459260B (zh) 2015-06-10
CA2791947A1 (fr) 2010-10-28
AU2010240742B2 (en) 2015-11-19
US20120115898A1 (en) 2012-05-10

Similar Documents

Publication Publication Date Title
ES2807221T3 (es) Derivados de 4-azaindol
JP2013529196A5 (enExample)
JP2017526726A5 (enExample)
NZ601077A (en) Use of an adrenal hormone-modifying agent
ES2546233T3 (es) Inhibidores de PI3K para el tratamiento del cáncer y enfermedades inmuno-inflamatorias
JP2015504061A5 (enExample)
ES2592404T3 (es) Benzotienopirimidinas sustituidas
TWI455939B (zh) ｃＭＥＴ抑制劑
IL256375A (en) New histological histories, process for their preparation and pharmaceutical preparations containing them
HRP20160396T1 (hr) Novi kiralni n-acil-5,6,7(8-susupstituirani)-tetrahidro-/1,2,4/triazolo/4,3-a/pirazini kao selektivni nk-3 receptor antagonisti, farmaceutski pripravak, i metode za upor
JP2017519754A5 (enExample)
CA2395593A1 (en) Azaindoles
RU2011121876A (ru) Пиразолопиримидиновые соединения-ингибиторы jak и способы
JP2018519323A5 (enExample)
JP2016172739A5 (enExample)
CN103328472A (zh) 作为呼吸道合胞病毒抗病毒剂的咪唑并吡啶
CN103339128A (zh) 作为呼吸道合胞病毒抗病毒剂的氮杂吲哚
HRP20141058T1 (hr) DERIVATI 1-PIRAZOLO[4,3-c]IZOKINOLINA, NJIHOVO DOBIVANJE I UPOTREBA U TERAPIJI
AR082986A1 (es) DERIVADOS DE PURINA COMO INHIBIDORES DE PI3K-d, METODOS PARA SU PREPARACION, FORMULACIONES FARMACEUTICAS QUE LOS COMPRENDEN Y SU USO EN EL TRATAMIENTO DE ENFERMEDADES HIPERPROLIFERATIVAS
HRP20230472T1 (hr) Novi derivati hidroksikiseline, postupak njihove priprave i farmaceutski sastavi koji ih sadrže
AR068057A1 (es) Esteres de 1-fenil-2-(3,5-dicloro)-piridina, metodo de preparacion de los mismos, composiciones farmaceuticas que los contienen y usos de los mismos para el tratamiento de enfermedades del tracto respiratorio.
PH12014500855A1 (en) Novel substituted imidazopyrimidines as gpbar1 receptor modulators
ME02388B (me) Sinteza n4-(2,2-dimetil-4-[(dihidrogen fosfonoksi)metil]-3-okso-5-pirido[1,4]oksazin-6- il)-5-fluoro-n2-(3,4,5-trimetoksifenil)-2,4-pirimidindiamin dinatrijum soli
JP2008508214A5 (enExample)
AR086676A1 (es) Derivados de alcoholes 1-fenil-2-piridinil alquilicos como inhibidores de fosfodiesterasa